☆ 4.6 Article

Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice

BEHAVIOURAL BRAIN RESEARCH (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Behavioral Sciences

Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner

Carley Marie Huffstetler et al.

Summary: This study investigated the immediate effects of a single dose of CBD on mouse behavior, specifically anxiety-like, attention-like, and memory behaviors. It found that CBD had different effects on male and female mice, with males showing a greater reduction in anxiety-like behaviors and females requiring a lower dose for the same effect. However, in Kv1.3-/- mice, CBD increased anxiety-like behaviors and reduced long-term object memory. Attention-like behaviors were not altered by CBD in wildtype mice, but Kv1.3-/- females exhibited decreased attention while males showed improved attention. These findings suggest that CBD's effects on behavior are dose, sex, and anxiety-state dependent.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2023)

添加到收藏夹

Article Neurosciences

Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors

Jaqueline M. Franzen et al.

Summary: Growing evidence suggests that cannabidiol (CBD) modulates aversive memories and anxiety-related responses in females. This has therapeutic implications for treating anxiety and stress-related disorders in women. Studies in adult female rats show that CBD can attenuate the behavioral manifestations of learned fear and anxiety.

NEUROPHARMACOLOGY (2023)

添加到收藏夹

Review Clinical Neurology

Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis

Caroline M. B. Kwee et al.

Summary: The endocannabinoid system shows promise as a potential therapy for anxiety, but its translation to the clinic has been slow. Using meta-analysis, this study examined the effects of compounds that facilitate endocannabinoid signaling on anxiety in humans and animals. The systematic review included 134 studies, and the results demonstrated that investigational drugs such as cannabidiol (CBD) were more effective than placebo/vehicle in reducing anxiety. However, the evidence quality was low, and more clinical trials are needed to further evaluate the clinical applications of these drugs.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

添加到收藏夹

Review Psychiatry

Symptom fluctuation over the menstrual cycle in anxiety disorders, PTSD, and OCD: a systematic review

Saria Adele Green et al.

Summary: Anxiety disorders tend to be more prevalent and severe in women than men, with menstrual cycle modulation affecting the severity and expression of symptoms across various disorders. Studies have shown exacerbation of symptoms in disorders such as panic disorder, PTSD, social anxiety disorder, and generalised anxiety disorder around the weeks before and after menses onset, with effects varied among individuals. Methodological weaknesses included inconsistent means of defining menstrual phases and small sample sizes, with future research potentially benefiting from larger samples and pre-screening for menstrual fluctuation history in anxiety symptoms.

ARCHIVES OF WOMENS MENTAL HEALTH (2022)

添加到收藏夹

Article Behavioral Sciences

Effects of cannabidiol and Δ9-tetrahydrocannabinol in the elevated plus maze in mice

Junhan Liu et al.

Summary: This study examined the effects of CBD, THC, and a combination of CBD and THC on anxiety using the elevated plus maze test. The results showed that CBD alone did not have a significant impact, while THC had anxiolytic effects at non-toxic doses. There was no significant difference between the effects of the combination of THC and CBD and THC alone.

BEHAVIOURAL PHARMACOLOGY (2022)

添加到收藏夹

Review Neurosciences

What's wrong with my experiment?: The impact of hidden variables on neuropsychopharmacology research

Hanna M. Butler-Struben et al.

Summary: Behavioral assays in neuropsychopharmacology are crucial for understanding mental illness and substance use disorders. However, hidden environmental factors that are often overlooked can significantly impact the results, suggesting the need for better reporting and consideration of these variables.

NEUROPSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Review Psychiatry

Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review

Ariel B. Handy et al.

Summary: This study synthesized the literature on the exacerbation of psychiatric symptoms across the menstrual cycle in adult women. The results showed that the premenstrual and menstrual phases were most consistently associated with symptom exacerbation. Strong evidence indicated increases in psychosis, mania, depression, suicide/suicide attempts, and alcohol use during these phases. Anxiety, stress, and binge eating appeared to be elevated more generally throughout the luteal phase. However, there were limited data and inconsistent patterns for other symptoms such as panic disorder, posttraumatic stress disorder, and borderline personality disorder.

HARVARD REVIEW OF PSYCHIATRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice

Amaya Austrich-Olivares et al.

Summary: The anxiolytic and antidepressant properties of cannabidiol (CBD) have been evaluated in several studies, but the molecular mechanisms are still unclear. This study found that CBD can modulate emotional disturbances and shows the highest effectiveness at a dose of 20mg/kg in mice. The cannabinoid receptor CB1 plays a significant role in the anxiolytic actions of CBD. CBD also modifies the gene expression of GABA(A) subunits alpha 2 and gamma 2 and CB1r, CB2r and GPR55, supporting a multimodal mechanism of action for CBD.

PHARMACEUTICALS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes

Hye Ji J. Kim et al.

Summary: The study found that female mice in proestrus were more sensitive to the anti-nociceptive effects of CP55,940 compared to those in metestrus, and proestrus mice exhibited increased expression of cannabinoid receptor type 1 in spine tissue.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)

Jose Diogo R. Souza et al.

Summary: Recent RCTs involving oral CBD administration for at least a week suggest that CBD has a good safety and tolerability profile, confirming previous data. However, it can potentially interact with other drugs and its use should be monitored, especially at the beginning of treatment.

PHARMACEUTICS (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Commonly-used rodent tests of anxiety-like behavior lack predictive validity for human sex differences

Stina Borchers et al.

Summary: Women are more likely to develop anxiety disorders than men. However, preclinical models of anxiety based on male rodents do not effectively predict sex differences. This study found that commonly used anxiety behavior tests did not reflect the sex difference in humans. The acoustic startle response test may be a better fit for modeling female anxiety-like behavior.

PSYCHONEUROENDOCRINOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze

Debora Fabris et al.

Summary: CBD exhibits anxiolytic effects in both male and female rats, with potential mechanisms involving GABA(A) receptor expression in females and 5-HT1A receptor activation in males. The responsiveness of female rats to CBD is influenced by the stage of the estrous cycle, with higher responsiveness observed in the late diestrus phase. After sub-chronic treatment, female rats in late diestrus maintain their responsiveness to CBD, while those in proestrus remain unresponsive.

JOURNAL OF PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice

Anna Paula Marcal et al.

Summary: This study investigated the effects of cannabidiol (CBD) treatment on behavior problems induced by a high-refined carbohydrate diet. The results demonstrated that sub-chronic treatment with CBD could alleviate the compulsive-like and anxiogenic-like behavior caused by long-term consumption of a high-refined carbohydrate diet.

METABOLIC BRAIN DISEASE (2022)

添加到收藏夹

Review Psychiatry

What Pre-clinical Rat Models Can Tell Us About Anxiety Across the Menstrual Cycle in Healthy and Clinically Anxious Humans

Jodie E. Pestana et al.

Summary: Anxiety symptoms increase during the peri-menstrual phase, both in healthy individuals and clinical populations, with heterogeneous effects reported across studies. Rodent models are valuable in identifying biological mechanisms and insights into menstrual-related changes in anxiety. Future research should focus on aligning methodologies across species and understanding individual factors influencing the propensity for experiencing menstrual-related changes in anxiety.

CURRENT PSYCHIATRY REPORTS (2022)

添加到收藏夹

Review Psychiatry

Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies

Louise Nora Nolan et al.

Summary: Hormonal fluctuations during the menstrual cycle may exacerbate symptoms of certain mental disorders, particularly during the premenstrual phase. However, the mixed evidence and methodological limitations of the studies may contribute to the inconsistent findings.

ARCHIVES OF WOMENS MENTAL HEALTH (2022)

添加到收藏夹

Review Psychiatry

The Impact of the Menstrual Cycle and Underlying Hormones in Anxiety and PTSD: What Do We Know and Where Do We Go From Here?

Yael Nillni et al.

Summary: Recent literature suggests that the menstrual cycle and its hormones impact symptoms and processes relevant to anxiety and PTSD. However, methodological limitations and inconsistent definitions of menstrual cycle phases contribute to conflicting results, highlighting the need for further research to inform personalized prevention and intervention efforts for women.

CURRENT PSYCHIATRY REPORTS (2021)

添加到收藏夹

Article Clinical Neurology

Enhanced responsiveness to hypoxic panicogenic challenge in female rats in late diestrus is suppressed by short-term, low-dose fluoxetine: Involvement of the dorsal raphe nucleus and the dorsal periaqueductal gray

Matheus F. Batistela et al.

Summary: Acute hypoxia induces panic-like escape behavior in both male and female rats. Females, especially in late diestrus phase, show a stronger response to hypoxia compared to males. Low-dose fluoxetine treatment can mitigate the exaggerated response of female rats in late diestrus phase.

JOURNAL OF PSYCHOPHARMACOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

Philippe A. Melas et al.

Summary: CBD, as the most abundant non-psychoactive component of cannabis, has received attention for its anxiolytic and antidepressant properties. Even though the exact molecular mechanism of action of CBD remains unknown, preclinical animal studies support its potential as an anxiolytic- and antidepressant-like compound. Additionally, evidence linking the neuropharmacological effects of CBD to its behavioral effects suggests a promising role in treating anxiety and mood disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders

Franciele F. Scarante et al.

Summary: CBD, a phytocannabinoid, has potential therapeutic effects in neurological and psychiatric disorders, though the exact pharmacological mechanisms remain uncertain. Studies suggest that CBD may mediate some of its effects by interfering with glial cell function.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Neurosciences

Female but not male rats show biphasic effects of low doses of Δ9 -tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?

Beatriz Zanutto Salviato et al.

Summary: In female rats, low doses of THC have biphasic effects on anxiety, being anxiolytic at low doses and anxiogenic at higher doses. CBD can mitigate high-dose THC side effects and enhance the anxiolytic effects of low doses in females. These effects are likely mediated by dopaminergic and serotoninergic neurotransmissions in the mPFC and NAc.

NEUROPHARMACOLOGY (2021)

添加到收藏夹

Review Neurosciences

Endocannabinoids, cannabinoids and the regulation of anxiety

Gavin N. Petrie et al.

Summary: Endocannabinoids and exogenous cannabinoids play important roles in the generation and termination of anxiety states. Disruption of the endogenous cannabinoid system can lead to anxiety states, while upregulation of the eCB signaling pathway can alleviate anxiety-like behaviors. Studies have shown that cannabinoids have the potential to regulate both the manifestation and amelioration of anxiety symptoms, highlighting the therapeutic potential of targeting the eCB system for novel anxiolytics.

NEUROPHARMACOLOGY (2021)

添加到收藏夹

Review Psychiatry

Effect of Estrous Cycle on Behavior of Females in Rodent Tests of Anxiety

Thelma A. Lovick et al.

Summary: In the field of anxiety disorders, there is a pressing need to validate and standardize experimental protocols for using female animal models. Despite potential differences based on sex, strain, and cyclical factors, females tend to perform similarly to males in many anxiety and fear behavioral tests.

FRONTIERS IN PSYCHIATRY (2021)

添加到收藏夹

Review Agriculture, Dairy & Animal Science

Levelling the Translational Gap for Animal to Human Efficacy Data

Guilherme S. Ferreira et al.

ANIMALS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

Maria S. Garcia-Gutierrez et al.

BIOMOLECULES (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Diversity of molecular targets and signaling pathways for CBD

Douglas L. de Almeida et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease

Serena Silvestro et al.

MOLECULES (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence

Madison Wright et al.

CANNABIS AND CANNABINOID RESEARCH (2020)

添加到收藏夹

Article Behavioral Sciences

Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent

Chelsea R. Kasten et al.

FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)

添加到收藏夹

Article Clinical Neurology

Short-term, low-dose fluoxetine prevents oestrous cycle-linked increase in anxiety-like behaviour in female rats

Rebeca Machado Figueiredo et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2019)

添加到收藏夹

Article Behavioral Sciences

Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism

Jerzy Zieba et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)

添加到收藏夹

Article Psychiatry

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

Ila M. Linares et al.

BRAZILIAN JOURNAL OF PSYCHIATRY (2019)

添加到收藏夹

Article Neurosciences

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

Manoela V. Fogaca et al.

NEUROPHARMACOLOGY (2018)

添加到收藏夹

Article Clinical Neurology

Panic-like escape response elicited in mice by exposure to CO2, but not hypoxia

Ailton Spiacci et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes

Gemma Navarro et al.

BIOCHEMICAL PHARMACOLOGY (2018)

添加到收藏夹

Review Immunology

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

Jose A. Crippa et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Chemistry, Medicinal

Dose translation between laboratory animals and human in preclinical and clinical phases of drug development

Anroop Nair et al.

DRUG DEVELOPMENT RESEARCH (2018)

添加到收藏夹

Article Behavioral Sciences

The endocannabinoid system as a target for novel anxiolytic drugs

Sachin Patel et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)

添加到收藏夹

Article Physiology

Influence of estrous cycle hormonal fluctuations and gonadal hormones on the ventilatory response to hypoxia in female rats

Danuzia A. Marques et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors

T. Bakas et al.

PHARMACOLOGICAL RESEARCH (2017)

添加到收藏夹

Article Neurosciences

Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats

Erin M. Rock et al.

PSYCHOPHARMACOLOGY (2017)

添加到收藏夹

Article Pharmacology & Pharmacy

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

Antonio W. Zuardi et al.

Frontiers in Pharmacology (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies

Kerstin Iffland et al.

CANNABIS AND CANNABINOID RESEARCH (2017)

添加到收藏夹

Article Clinical Neurology

Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice

Angelica Pupin Schiavon et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)

添加到收藏夹

Article Psychiatry

CO2 exposure as translational cross-species experimental model for panic

N. K. Leibold et al.

TRANSLATIONAL PSYCHIATRY (2016)

添加到收藏夹

Article Behavioral Sciences

Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences

A. L. Z. Marinho et al.

BEHAVIOURAL BRAIN RESEARCH (2015)

添加到收藏夹

Article Pharmacology & Pharmacy

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

R. B. Laprairie et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

添加到收藏夹

Article Clinical Neurology

Elevation of brain allopregnanolone rather than 5-HT release by short term, low dose fluoxetine treatment prevents the estrous cycle-linked increase in stress sensitivity in female rats

Adam J. Devall et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

添加到收藏夹

Article Neurosciences

SEROTONIN IN THE DORSAL PERIAQUEDUCTAL GRAY INHIBITS PANIC-LIKE DEFENSIVE BEHAVIORS IN RATS EXPOSED TO ACUTE HYPOXIA

A. Spiacci et al.

NEUROSCIENCE (2015)

添加到收藏夹

Review Clinical Neurology

Molecular Targets of Cannabidiol in Neurological Disorders

Clementino Ibeas Bih et al.

NEUROTHERAPEUTICS (2015)

添加到收藏夹

Review Endocrinology & Metabolism

Sex differences in anxiety and depression clinical perspectives

Margaret Altemus et al.

FRONTIERS IN NEUROENDOCRINOLOGY (2014)

添加到收藏夹

Article Clinical Neurology

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system

Alline C. Campos et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)

添加到收藏夹

Article Clinical Neurology

The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)

Andre Twardowschy et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2013)

添加到收藏夹

Article Neurosciences

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

Alline Cristina Campos et al.

PSYCHOPHARMACOLOGY (2013)

添加到收藏夹

Article Psychiatry

The role of menstrual cycle phase and anxiety sensitivity in catastrophic misinterpretation of physical symptoms during a CO2 challenge

Yael I. Nillni et al.

ARCHIVES OF WOMENS MENTAL HEALTH (2012)

添加到收藏夹

Review Biology

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Alline Cristina Campos et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)

添加到收藏夹

Article Neurosciences

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour

Serena Deiana et al.

PSYCHOPHARMACOLOGY (2012)

添加到收藏夹

Article Psychiatry

Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness

Carmen P. McLean et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2011)

添加到收藏夹

Article Neurosciences

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients

Mateus M. Bergamaschi et al.

NEUROPSYCHOPHARMACOLOGY (2011)

添加到收藏夹

Article Behavioral Sciences

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

Vanessa de Paula Soares et al.

BEHAVIOURAL BRAIN RESEARCH (2010)

添加到收藏夹

Article Pharmacology & Pharmacy

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

T. V. Zanelati et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

添加到收藏夹

Article Neurosciences

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

Alline Cristina Campos et al.

PSYCHOPHARMACOLOGY (2008)

添加到收藏夹

Article Neurosciences

Neuronal excitability in the periaqueductal grey matter during the estrous cycle in female Wistar rats

K. E. Brack et al.

NEUROSCIENCE (2007)

添加到收藏夹

Article Psychology, Clinical

Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers

JE Bailey et al.

DEPRESSION AND ANXIETY (2005)

添加到收藏夹

Article Pharmacology & Pharmacy

Cannabidiol: An overview of some pharmacological aspects

R Mechoulam et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.